Malignant pleural effusion: from bench to bedside

被引:187
|
作者
Psallidas, Ioannis [1 ]
Kalomenidis, Ioannis [2 ]
Porcel, Jose M. [3 ]
Robinson, Bruce W. [4 ,5 ]
Stathopoulos, Georgios T. [6 ,7 ,8 ,9 ]
机构
[1] Oxford Univ Hosp Trust, Oxford Ctr Resp Med, Oxford Resp Trials Unit, Oxford, England
[2] Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care & Pulm Med 1, Athens, Greece
[3] Arnau de Vilanova Univ Hosp, Biomed Res Inst Lleida, Dept Internal Med, Pleural Med Unit, Lleida, Spain
[4] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Perth, WA, Australia
[5] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia
[6] Univ Patras, Fac Med, Dept Physiol, Lab Mol Resp Carcinogenesis, Achaia, Greece
[7] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Pneumol Ctr CPC, Munich, Germany
[8] Helmholtz Zentrum Munchen, Munich, Germany
[9] German Ctr Lung Res DZL, Munich, Germany
基金
欧洲研究理事会;
关键词
MESOTHELIAL CELLS; T-CELLS; DIFFERENTIAL-DIAGNOSIS; LUNG ADENOCARCINOMA; CYTOTOXIC ACTIVITY; TALC PLEURODESIS; MOUSE MODEL; CHEST TUBE; EFFICACY; SURVIVAL;
D O I
10.1183/16000617.0019-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor quality of life, morbidity and mortality. Its incidence and associated healthcare costs are rising and its management remains palliative, with median survival ranging from 3 to 12 months. During the last decade there has been significant progress in unravelling the pathophysiology of MPE, as well as its diagnostics, imaging, and management. Nowadays, formerly bed-ridden patients are genotyped, phenotyped, and treated on an ambulatory basis. This article attempts to provide a comprehensive overview of current advances in MPE from bench to bedside. In addition, it highlights unanswered questions in current clinical practice and suggests future directions for basic and clinical research in the field.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [41] Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion
    Wu, Da-Wei
    Chang, Wei-An
    Liu, Kuan-Ting
    Yen, Meng-Chi
    Kuo, Po-Lin
    ONCOLOGY LETTERS, 2017, 14 (03) : 3657 - 3662
  • [42] Malignant pleural effusion and algorithm management
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Tsakiridis, Kosmas
    Machairiotis, Nikolaos
    Kougioumtzi, Ioanna
    Courcoutsakis, Nikolaos
    Terzi, Eirini
    Zaric, Bojan
    Huang, Haidong
    Freitag, Lutz
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S413 - S419
  • [43] Individualised management of malignant pleural effusion
    Clive, Amelia O.
    Bhatnagar, Rahul
    Psallidas, Ioannis
    Maskell, Nick A.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (07) : 505 - 506
  • [44] Treatment options for malignant pleural effusion
    Musani, Ali I.
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (04) : 380 - 387
  • [45] THORACOSCOPIC MANAGEMENT OF MALIGNANT PLEURAL EFFUSION
    BAL, S
    HASAN, SS
    INTERNATIONAL SURGERY, 1993, 78 (04) : 324 - 327
  • [46] BEVACIZUMAB TREATMENT OF MALIGNANT PLEURAL EFFUSION
    Gu, Yan
    Yang, Wanung
    Zhang, Min
    Yang, Xiaolu
    Fu, Xinhua
    ACTA MEDICA MEDITERRANEA, 2021, 37 (05): : 2631 - 2637
  • [47] Surgical treatment in malignant pleural effusion
    Karadayi, Sule
    Sahin, Ekber
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 29 (04): : 577 - 585
  • [48] Treatment Approaches for Malignant Pleural Effusion
    Yagi, Yukako
    Kosugi, Kazuhiro
    Tanimoto, Tetsuya
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1506 - 1507
  • [49] Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion
    Ai, Ling
    Wang, Wenjun
    Li, Jingyuan
    Ye, Ting
    Li, Yuying
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (02) : 136 - 142
  • [50] The diagnostic value of pleural fluid homocysteine in malignant pleural effusion
    Santotoribio, Jose D.
    del Valle-Vazquez, Luis
    Garcia-de la Torre, Angela
    del Castillo-Otero, Daniel
    Lopez-Saez, Juan-Bosco
    Sanchez del Pino, Maria J.
    PLOS ONE, 2019, 14 (09):